Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 13, 2000 - Issue 4
Submit an article Journal homepage
108
Views
1
CrossRef citations to date
0
Altmetric
Articles

Treatment Options for Clinical Stage 1 Testis Cancer

Arthur I. Sagalowsky
, MD
Pages 372-375 | Published online: 11 Dec 2017

  • SEER Cancer Statistics Review, NCI monograph, 1996.
  • Sagalowsky AI. Current considerations in the diagnosis and initial treatment of testicular cancer. Compr Ther 1994;20: 688–694.
  • Foster RS, Ragan DC, Birhle R, Wahle GR, Hermans BP, Donohue JP. Fertility update on nerve sparing RPLND in clinical stage 1 nonseminoma. J Urol 1998;159: Ab174.
  • Janetschek G, Hobisch A, Peschel R, Hittmair A, Bartsch G. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: long-term outcome. J Urol 2000;163: 1793–1796.
  • Sogani PC, Perrotti M, Rabbani F, Herr HW, Fair WR, Bosl G. Long-term outcome of patients with clinical stage 1 testis cancer on surveillance. J Urol 1998;159: Ab184.
  • Swanson DA, von Eschenbach AC, Babian RJ, Dinney CPN, Pisters LL, Pettaway CA. Is retroperitoneal lymph node dissection (RPLND) alone optimal or sufficient therapy for clinical stage 1 nonseminomatous germ cell testicular tumors (NSGCTT) at high risk for relapse? J Urol 1998;159: Ab179.
  • Hermans BP, Sweeney CJ, Foster RS, Einhorn LE, Donohue JP. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection. J Urol 2000;163: 1721–1724.
  • Moul JW, Snow PB, Fernandez EB, Maher PD, Sesterhenn IA. Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage I nonseminomatous testicular cancer. J Urol 1995; 153: 1674–1677.
  • Amato R, Banks E, Ro J, Swanson DA. Postorchiectomy adjuvant chemotherapy for patients with clinical stage 1 nonseminomatous germ cell tumors of the testis (NSGCTT) at high risk for relapse. J Urol 1999;161: Ab604.
  • Kratzik C, Reiter WJ, Schrey A. Ten years experience with adjuvant singleagent carboplatin therapy for clinical stage 1 seminoma. J Urol 1999;161: Ab700.
  • Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Van Leeuwen FE, Kohler BA, Pukkala E, Lynch CF, Andersson M, Bergfeldt K, Clarke EA, Wiklund T, Stoter G, Gospodarowicz M, Sturgeon J, Fraumeni JF Jr, Boice JD Jr. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997;89: 1429–1439.
  • Leibovitch I, Ramon J, Hayman Z, Tel-Hashomer, Baniel J, Livne P, Petach-Tiqua, Vardi Y, Nativ O, Meretik S. Annual ultrasonographic screening of the remaining testis following unilateral radical orchiectomy for testicular germ cell tumor. A prospective multicenter study. J Urol 1999;161: Ab708.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.